Relationships between serum HER2 ECD, TIMP-1 and clinical outcomes in Taiwanese breast cancer

BACKGROUND: Serum levels of the extracellular domain of HER2/neu (HER2 ECD) have been demonstrated to be associated with clinical outcomes. A disintegrin and metalloproteinase-10, a sheddase of HER2/neu, can drive cancer progression and its activity is inhibited by tissue inhibitor of metalloprotein...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hsiu-Pei, Chen, Shin-Cheh, Chien, Huei-Tzu, Jan, Yi-Yin, Chao, Tzu-Chieh, Chen, Miin-Fu, Hsieh, Ling-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312842/
https://www.ncbi.nlm.nih.gov/pubmed/22339939
http://dx.doi.org/10.1186/1477-7819-10-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312842/
https://www.ncbi.nlm.nih.gov/pubmed/22339939
http://dx.doi.org/10.1186/1477-7819-10-42

Ejemplares similares